Business Description
Immunovant Inc
NAICS : 325199
SIC : 2834
ISIN : US45258J1025
Description
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10062.57 | |||||
| Equity-to-Asset | 0.87 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -16.7 | |||||
| 3-Year EPS without NRI Growth Rate | -14 | |||||
| 3-Year FCF Growth Rate | -17.7 | |||||
| 3-Year Book Growth Rate | 2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -18.79 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.26 | |||||
| 9-Day RSI | 31.22 | |||||
| 14-Day RSI | 37.18 | |||||
| 3-1 Month Momentum % | -2.6 | |||||
| 6-1 Month Momentum % | 8.65 | |||||
| 12-1 Month Momentum % | -33.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.61 | |||||
| Quick Ratio | 7.61 | |||||
| Cash Ratio | 7.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.1 | |||||
| Shareholder Yield % | 0.02 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -63.52 | |||||
| ROA % | -58.19 | |||||
| ROIC % | -3539.48 | |||||
| 3-Year ROIIC % | -2123.79 | |||||
| ROC (Joel Greenblatt) % | -50279.03 | |||||
| ROCE % | -69.31 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 8.59 | |||||
| Price-to-Tangible-Book | 8.59 | |||||
| EV-to-EBIT | -10.15 | |||||
| EV-to-Forward-EBIT | -10.68 | |||||
| EV-to-EBITDA | -10.16 | |||||
| EV-to-Forward-EBITDA | -10.68 | |||||
| EV-to-FCF | -13.14 | |||||
| Price-to-Net-Current-Asset-Value | 8.73 | |||||
| Price-to-Net-Cash | 9.49 | |||||
| Earnings Yield (Greenblatt) % | -9.85 | |||||
| FCF Yield % | -7.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IMVT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Immunovant Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.22 | ||
| Beta | 0.7 | ||
| 3-Year Sharpe Ratio | 0.79 | ||
| 3-Year Sortino Ratio | 2.39 | ||
| Volatility % | 29.17 | ||
| 14-Day RSI | 37.18 | ||
| 14-Day ATR ($) | 1.126304 | ||
| 20-Day SMA ($) | 27.5435 | ||
| 12-1 Month Momentum % | -33.7 | ||
| 52-Week Range ($) | 24.61 - 45.58 | ||
| Shares Outstanding (Mil) | 146.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Immunovant Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Immunovant Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Immunovant Inc Frequently Asked Questions
What is Immunovant Inc(IMVT)'s stock price today?
The current price of IMVT is $26.28. The 52 week high of IMVT is $45.58 and 52 week low is $24.61.
When is next earnings date of Immunovant Inc(IMVT)?
The next earnings date of Immunovant Inc(IMVT) is 2025-02-12 Est..
Does Immunovant Inc(IMVT) pay dividends? If so, how much?
Immunovant Inc(IMVT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers